Results 31 to 40 of about 79,111 (213)
Angiotensin II receptor blockers and insulin resistance [PDF]
Hypertension Research, 2010 n ...
openaire +3 more sources
Cutaneous ulcers in association with sprue‐like enteropathy secondary to Losartan
Clinical Case Reports, 2021 Losartan is an angiotensin II receptor blocker (ARB) which may cause severe sprue‐like enteropathy (SLE) with skin manifestation. Clinicians should be informed of this side effect and its reversibility after cessation of the drug.
Francis Essien +3 more
doaj +1 more source
Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction [PDF]
, 2011 <b>Background</b> Meta-analysis of small trials suggests that pharmacist-led collaborative review and revision of medical treatment may improve outcomes in heart failure.<p></p> <b>Methods and results</b> We studied
Forsyth, P. +7 more
core +1 more source
Endothelial-Dependent and Independent Vascular Relaxation Effect of Tetrahydropalmatine on Rat Aorta
Frontiers in Pharmacology, 2019 Tetrahydropalmatine (THP) is an active natural alkaloid isolated from Corydalis yanhusuo W.T. Wang which has been widely used for treating pain and cardiovascular disease in traditional Chinese medicine.
Zhong-Yan Zhou +11 more
doaj +1 more source
Beta-blocker under-use in COPD patients [PDF]
, 2017 Background: Cardiovascular (CVS) comorbidities are common in COPD and contribute significantly to morbidity and mortality, especially following acute exacerbations of COPD (AECOPD).
Lavender, Melanie +4 more
core +2 more sources
Journal of Pharmacoeconomics and Pharmaceutical Management, 2023 Background Hypertension is a chronic disease that cannot be cured and can only be controlled but requires long-term treatment, even for life. The variety of antihypertensive treatments makes it necessary to adjust the choice of treatment not only in ...
Ida Adhayanti +2 more
doaj +1 more source
Acute kidney injury: an acceptable risk of treatment with renin-angiotensin system blockade in primary care? [PDF]
, 2015 Background: Use of renin-angiotensin system (RAS) blockade has become increasingly widespread driven by evidence-based guidance. There is concern about the role of these agents in the genesis of avoidable acute kidney injury (AKI).
Bellomo R +7 more
core +2 more sources
Molecular targeting therapy with angiotensin II receptor blocker for prostatic cancer
Oncology Reviews, 2011 Angiotensin II (Ang-II) plays a key role as a vasoconstrictor in controlling blood pressure and electrolyte/fluid homeostasis. Recently it has also been shown that this peptide is a cytokine, acting as a growth factor in cardiovascular and stromal cells.
Hiroji Uemura +2 more
doaj +2 more sources
Case Reports in Medicine, 2011 Introduction. Overdose with the calcium channel blocker amlodipine can cause profound hypotension that may be exacerbated by the concurrent ingestion of an angiotensin II receptor antagonist.
James O. M. Plumb +3 more
doaj +1 more source
Angiotensin II receptor blockers in dermatology: a narrative review
Journal of Dermatological Treatment, 2022 Angiotensin II receptor blockers (ARBs) are commonly used for cardiovascular diseases, especially for patients who can't tolerate the side effects of cough and angioedema caused by angiotensin converting enzyme inhibitors (ACEIs). However, the evidence of using ARBs in dermatology is mostly anecdotal and limited to case reports or small case series ...
Yang, Lo, Tsen-Fang, Tsai
openaire +2 more sources